Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figure in Item 6 represents shares of Common Stock, $0.0001 par value per share ("Common Stock") of Gossamer Bio, Inc. (the "Issuer") held by DCIG Capital Master Fund LP, a Delaware limited partnership (the "Fund"). (2) The figures in Items 8 and 9 include: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 represent shares of Common Stock held by the Fund. (2) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figure in Items 6 represents shares of Common Stock held by the Fund. (2) The figures in Items 8 and 9 includes: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G



 
DeepCurrents Investment Group LLC
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member and President
Date:06/11/2026
 
DCIG GP LLC
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
 
DCIG Capital Master Fund LP
 
Signature:DCIG GP LLC
Name/Title:General Partner
Date:06/11/2026
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
 
Kai Zheng
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng
Date:06/11/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement (filed herewith).


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1